GemVax & KAEL Co (XKRX:082270) Debt-to-Equity : 0.14 (As of Dec. 2023)

View and export this data going back to 2005. Start your Free Trial

What is GemVax & KAEL Co Debt-to-Equity?

GemVax & KAEL Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was ₩14,048 Mil. GemVax & KAEL Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was ₩495 Mil. GemVax & KAEL Co's Total Stockholders Equity for the quarter that ended in Dec. 2023 was ₩108,019 Mil. GemVax & KAEL Co's debt to equity for the quarter that ended in Dec. 2023 was 0.13.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for GemVax & KAEL Co's Debt-to-Equity or its related term are showing as below:

XKRX:082270' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.04 Med: 0.22 Max: 4.53
Current: 0.14

During the past 13 years, the highest Debt-to-Equity Ratio of GemVax & KAEL Co was 4.53. The lowest was 0.04. And the median was 0.22.

XKRX:082270's Debt-to-Equity is ranked better than
63.96% of 874 companies
in the Semiconductors industry
Industry Median: 0.26 vs XKRX:082270: 0.14

GemVax & KAEL Co Debt-to-Equity Historical Data

The historical data trend for GemVax & KAEL Co's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GemVax & KAEL Co Debt-to-Equity Chart

GemVax & KAEL Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Equity

Get a 7-Day Free Trial

0.16

0.07

0.04

0.05

0.14

GemVax & KAEL Co Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Debt-to-Equity	Get a 7-Day Free Trial															0.05	0.07	0.04	0.03	0.14

Competitive Comparison of GemVax & KAEL Co's Debt-to-Equity

For the Semiconductor Equipment & Materials subindustry, GemVax & KAEL Co's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

GemVax & KAEL Co's Debt-to-Equity Distribution in the Semiconductors Industry

For the Semiconductors industry and Technology sector, GemVax & KAEL Co's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where GemVax & KAEL Co's Debt-to-Equity falls into.

GemVax & KAEL Co Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

GemVax & KAEL Co's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(14047.616	+	495.286)	/	108018.656
	=	0.13

GemVax & KAEL Co's Debt to Equity Ratio for the quarter that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(14047.616	+	495.286)	/	108018.656
	=	0.13

GemVax & KAEL Co (XKRX:082270) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

GemVax & KAEL Co Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of GemVax & KAEL Co's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

GemVax & KAEL Co (XKRX:082270) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Technology » Semiconductors » GemVax & KAEL Co Ltd (XKRX:082270) » Definitions » Debt-to-Equity

Traded in Other Exchanges

N/A

Address

894, Tamnip-Dong, Yuseong-Gu, Daejeon, KOR, 305-510

Website

http://www.kael.co.kr

GemVax & KAEL Co Ltd is primarily engaged in manufacturing and commercializing of coating resin and filters for semiconductors and panel display production. It offers chemical air filter, scrubber resin, and devices for preventing environmental contamination and eliminating harmful gas, for semiconductor and display industry. Its other business operations include research and development of anti-cancer immunotherapeutic and peptide drugs. The company organizes its business operations into three distinct segments: Environmental Pollution Control Business, IT Business, Bio-business. The company's product portfolio consists fundamental products, semiconductor, and display, equipment and system, fire evacuation mask 5aver.

GemVax & KAEL Co (XKRX:082270) Headlines

No Headlines